SCHEMBL1287170

SCHEMBL1287170

COCc1csc(C(Cc2cccc(NS(=O)(=O)O)c2)NC(=O)C(Cc2ccccc2)NC(=O)OC)n1

nearest known ligand 0.86

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
PTPRB P23467 20/20 0.86

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL680122 0.93 PTPRB (1.00) PTPRB
SCHEMBL680123 0.93 PTPRB (1.00) PTPRB
SCHEMBL16061190 0.91 PTPRB (0.87) PTPRB
SCHEMBL16060955 0.91 PTPRB (0.87) PTPRB
SCHEMBL16059578 0.90 PTPRB (0.86) PTPRB
SCHEMBL16061768 0.87 PTPRB (0.86) PTPRB
SCHEMBL16060484 0.87 PTPRB (0.87) PTPRB
SCHEMBL16061033 0.86 PTPRB (0.87) PTPRB
SCHEMBL16943453 0.86 PTPRB (0.86) PTPRB
SCHEMBL16060586 0.85 PTPRB (0.87) PTPRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2967066-A1 COMPOSITIONS, FORMULATIONS AND METHODS FOR TREATING OCULAR DISEASES Aerpio Therapeutics Inc. (US) 2016-01-20 EP disclosed
WO-2014145068-A1 COMPOSITIONS, FORMULATIONS AND METHODS FOR TREATING OCULAR DISEASES AERPIO THERAPEUTICS INC. (US) 2014-09-18 WO disclosed